the incidences of diarrhea ( 13.0 % ) and atypical lethargy ( 11.6 % ) were higher ( p less than .025 and p less than .05 , respectively ) after ipecac-induced emesis than in patients not receiving ipecac syrup .
C0042963
emesis
C0022046
ipecac syrup